FDA Inspection 1278509 — Vitalant

Vitalant — FEI 2971465

The FDA completed an inspection of Vitalant on July 31, 2025 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reno, NV (United States)